Glutathione Participation in the Prevention of Cardiovascular Diseases

• Published in: Antioxidants 2021-07, Vol.10 (8), p.1220
• Main Authors: Matuz-Mares, Deyamira, Riveros-Rosas, Héctor, Vilchis-Landeros, María Magdalena, Vázquez-Meza, Héctor
• Format: Article
• Language: English
• Subjects: Aging; Amino acids; Antioxidants; Cardiovascular disease; Cardiovascular diseases; Coronary artery; Coronary artery disease; Cytochrome; Diabetes; Enzymes; Free radicals; Glutathione; Heart; Heart diseases; Homeostasis; Hydrogen peroxide; Hydroxyl radicals; Hypochlorous acid; Metabolism; Nitric oxide; Occlusion; Oxidation; Oxidative stress; Oxidizing agents; Peroxynitrite; Physiology; Reactive nitrogen species; Reactive oxygen species; Review; Superoxide anions
• ISSN: 2076-3921; 2076-3921
• DOI: 10.3390/antiox10081220

Cardiovascular diseases (CVD) (such as occlusion of the coronary arteries, hypertensive heart diseases and strokes) are diseases that generate thousands of patients with a high mortality rate worldwide. Many of these cardiovascular pathologies, during their development, generate a state of oxidative stress that leads to a deterioration in the patient's conditions associated with the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Within these reactive species we find superoxide anion (O ), hydroxyl radical ( OH), nitric oxide (NO ), as well as other species of non-free radicals such as hydrogen peroxide (H O ), hypochlorous acid (HClO) and peroxynitrite (ONOO ). A molecule that actively participates in counteracting the oxidizing effect of reactive species is reduced glutathione (GSH), a tripeptide that is present in all tissues and that its synthesis and/or regeneration is very important to be able to respond to the increase in oxidizing agents. In this review, we will address the role of glutathione, its synthesis in both the heart and the liver, and its importance in preventing or reducing deleterious ROS effects in cardiovascular diseases.